Clinical Trial: Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Study Status: Completed
Recruit Status: RECRUITING
Condition: Netherton Syndrome
Study Type: INTERVENTIONAL
Official Title: A Multicenter, Open Label Study of QRX003 Lotion in Subjects With Netherton Syndrome
Brief Summary:
To assess the safety, tolerability, and efficacy of QRX003 lotion (4%) when added to standard of care treatment regimen, including systemic therapy in subjects with Netherton syndrome
Read more